Clinical Trials Sponsored by Instituto Lala
Total 74603 results
-
National Cancer Institute (NCI)RecruitingKidney Cancer | Bladder Cancer | Renal Cancer | Malignant Neoplasms | Hereditary Neoplastic SyndromesUnited States
-
National Cancer Institute (NCI)RecruitingHIV | Kaposi's Sarcoma | Primary Effusion Lymphoma | Lymphomas | Multicentric Castleman's DiseaseUnited States
-
National Cancer Institute (NCI)RecruitingMelanoma | Colorectal Cancer | Lung Cancer | Bladder Cancer | Synovial Cell CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingBurkitt Lymphoma | Primary Mediastinal Large B-cell Lymphoma | Gray Zone Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Anaplastic Large-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedNeurofibroma | Neurofibromatosis Type 1United States
-
National Cancer Institute (NCI)Enrolling by invitationMelanoma | Adenocarcinoma | Neuroendocrine Tumors | Carcinoma NOSUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedLeukemia | Multiple Myeloma | MGUS | Monoclonal B-Cell LymphocytosisUnited States
-
National Cancer Institute (NCI)Enrolling by invitation
-
National Cancer Institute (NCI)Active, not recruitingProstate Cancer | Neoplasms of Prostate | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States
-
Ottawa Heart Institute Research CorporationCanadian Institutes of Health Research (CIHR)Active, not recruitingAtrial Fibrillation | Heart Disease | Congestive Heart FailureCanada
-
National Cancer Institute (NCI)Enrolling by invitationProstate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States
-
National Cancer Institute (NCI)Enrolling by invitationSolid Tumors | Hematologic Malignancies | Pediatric CancersUnited States
-
National Cancer Institute (NCI)CompletedParents of Children With Cancer | Parents of Children With NF1 | Parents of Children With Neurofibromatosis Type IUnited States, Canada
-
National Cancer Institute (NCI)CompletedNSCLC | Solid Tumors | Lymphomas | Granulosa Cell Ovarian Cancer | Metastatic Colon CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)CompletedCancer | Brain MetastasisUnited States
-
National Cancer Institute (NCI)Enrolling by invitation
-
National Cancer Institute (NCI)Active, not recruitingHormone Receptor-Positive Breast | Gynecologic | Desmoid | Hormone Receptor-Positive NeoplasmsUnited States
-
National Eye Institute (NEI)CompletedAge-Related Macular Degeneration | Macular DegenerationUnited States
-
National Eye Institute (NEI)Active, not recruitingAge-Related Macular Degeneration | CataractUnited States
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)Enrolling by invitationCervical Intraepithelial Neoplasia | Oropharyngeal Neoplasms | Squamous Intraepithelial Lesions of the Cervix | Cervical Neoplasms | Hematologic MalignaciesUnited States
-
Mayo ClinicNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedGastrointestinal Disease | Cancer ColonUnited States
-
National Cancer Institute (NCI)CompletedLung CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingBrain Cancer | Brain Tumor | Neoplasm | Spine Cancer | Spine TumorUnited States
-
Stanford UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)SuspendedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Acute LeukemiaUnited States
-
National Eye Institute (NEI)CompletedAge-Related Macular DegenerationUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Central Nervous System NeoplasmUnited States
-
National Eye Institute (NEI)Completed
-
National Cancer Institute (NCI)CompletedGlioblastoma Multiforme | Gliosarcoma | Giant Cell Glioblastoma | Astrocytoma, Grade IVUnited States
-
National Cancer Institute (NCI)Active, not recruitingCentral Nervous System Lymphoma | Secondary Central Nervous System LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 (NF1) | Plexiform Neurofibromas (PN)United States
-
National Eye Institute (NEI)Active, not recruitingVon Hippel-Lindau Disease | Retinal HemangioblastomaUnited States
-
National Cancer Institute (NCI)TerminatedMesotheliomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Malignant Neoplasm to BrainUnited States
-
National Cancer Institute (NCI)Active, not recruitingCastrate Sensitive Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdrenocortical CarcinomaUnited States
-
National Eye Institute (NEI)TerminatedVon Hippel-Lindau SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingSmall Cell Lung Cancer | Extra-Pulmonary Small Cell CarcinomasUnited States
-
National Cancer Institute (NCI)CompletedRefractory Soft Tissue SarcomasUnited States
-
National Cancer Institute (NCI)Enrolling by invitationMultiple Myeloma | Hematologic Malignancies | Leukemia, B-cell | Lyphoma, B-CellUnited States
-
National Cancer Institute (NCI)CompletedDyskeratosis Congenita | Telomere Biology DisordersUnited States
-
National Cancer Institute (NCI)CompletedBurkitt Lymphoma | High-grade B-cell Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | T-cell/Histocyte-rich Large B-cell Lymphoma | Germinal Center B-cell Type (GCB)United States
-
National Cancer Institute (NCI)CompletedLymphoma | Diffuse Large B-Cell Lymphoma | Non-Hodgkin Lymphoma | Primary Central Nervous System Lymphoma | Gray-zone LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHairy Cell LeukemiaUnited States